| 000 | 01743 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513190118.0 | ||
| 264 | 0 | _c19990805 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0028-0836 | ||
| 024 | 7 |
_a10.1038/22326 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLowrie, D B | |
| 245 | 0 | 0 |
_aTherapy of tuberculosis in mice by DNA vaccination. _h[electronic resource] |
| 260 |
_bNature _cJul 1999 |
||
| 300 |
_a269-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBacterial Proteins |
| 650 | 0 | 4 | _aChaperonin 60 |
| 650 | 0 | 4 |
_aChaperonins _xgenetics |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-12 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-4 _xmetabolism |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aMycobacterium leprae _xgenetics |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xgenetics |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 |
_aPyrazinamide _xtherapeutic use |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTuberculosis _ximmunology |
| 650 | 0 | 4 |
_aVaccines, DNA _ximmunology |
| 700 | 1 | _aTascon, R E | |
| 700 | 1 | _aBonato, V L | |
| 700 | 1 | _aLima, V M | |
| 700 | 1 | _aFaccioli, L H | |
| 700 | 1 | _aStavropoulos, E | |
| 700 | 1 | _aColston, M J | |
| 700 | 1 | _aHewinson, R G | |
| 700 | 1 | _aMoelling, K | |
| 700 | 1 | _aSilva, C L | |
| 773 | 0 |
_tNature _gvol. 400 _gno. 6741 _gp. 269-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/22326 _zAvailable from publisher's website |
| 999 |
_c10379345 _d10379345 |
||